Guidelines

Is 8 Minutes of Exercise Enough?

A mere eight minutes of exercise a day – 54 minutes a week – is enough to lower the risk of early death and heart disease. 

In a study published in the European Heart Journal, scientists examined data from fitness trackers worn by nearly 72k people in the UK. After a 6-year mean follow-up, researchers found that eight minutes of vigorous physical activity a day lowered the risk of early death by 36%, and the risk of CVD by 35%. 

Here’s a sample of how different weekly exercise lengths correlated with mortality and cardiovascular disease incidents : 

  • 15 minutes/week → 16-18% lower all-cause mortality
  • 20 minutes/week → 40% lower CVD mortality
  • Further beneficial associations observed for up to 50-57 minutes per week. 

The people who exercised even more saw greater improvements, but the protective effects of vigorous exercise began to plateau around 54 minutes. 

The Takeaway

The CDC recommends at least 150 minutes of moderate intensity exercise or 75 minutes of vigorous exercise each week. But still, a majority of Americans fail to meet these guidelines. Perhaps aiming for eight minutes of intense movement each day may help make exercise more accessible and achievable.

It’s hard to keep up with all the data pertaining to optimal exercise routines for health and longevity. But all studies seem to agree that getting your body moving – even for just a handful of minutes – has life-changing effects. 

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Electrophysiology August 21, 2025

Conduction-System Pacing Succeeds at Treating AV Block August 21, 2025

Conduction-system pacing could be poised to reshape standard care for atrioventricular (AV) block patients after the randomized CSPACE trial demonstrated its significant benefits over traditional right ventricular septal pacing. Taking a closer look at CSP’s potential, the CSPACE trial enrolled 202 patients with AV block at two Australian hospitals, randomizing them to conduction-system pacing or […]

Cardiology Pharmaceuticals August 18, 2025

Rivaroxaban Monotherapy Could Be Better for CAD + AFib August 18, 2025

New analysis from the AFIRE trial suggests rivaroxaban monotherapy might be emerging as a preferred antithrombotic strategy for patients with AFib and stable coronary artery disease, especially in older age groups. The Post Hoc AFIRE Analysis examined 2,215 Japanese patients with AFib and stable CAD, stratifying them into four age groups (<70, 70-74, 75-79, and […]

Surgeries & Interventions August 14, 2025

TEER Could Save Lives in AFMR Patients August 14, 2025

Shedding light on a new treatment for an understudied condition, data published in EHJ suggests that transcatheter edge-to-edge repair (TEER) delivers significant survival advantages in patients with atrial functional mitral regurgitation (FMR). The new OCEAN-Mitral/REVEAL-AFMR Analysis compared 441 TEER-treated patients against 640 medically managed controls with moderate or severe atrial FMR, stating a solid case […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!